US Oncology Testing Market Shares and Sales Segment Forecasts By Assay, 2019-2023

This report provides an overview of the US cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.

Table of Contents

Business Environment
  1. Health Care Expenditures
  2. Cost Consciousness
  3. Industry Consolidation
  4. Managed Care
  5. Hospitals
  6. Admissions
  7. Length of Stay
  8. Industry Diversification
  9. Physician Demographics
10. Population Aging
      a. Chronic Illness
      b. Disease Incidence
      c. Susceptibility to Iatrogenesis
      d. Multiple Illness Cases
11. Laboratory Regulations

Market Structure
  1. Centralized Testing
      a. Hospitals
      b. Commercial/Private Laboratories
  2. Decentralized Testing
      a. Physician Offices/Group Practices
      b. Cancer Clinics
      c. Point-of-Care Testing
      d. Other Decentralized Testing Locations

Market Size, Growth, and Major Suppliers' Market Shares

List of Tables

Test Volume Forecasts by Market Segment
               
Sales Forecasts by Market Segment

AFP Testing: Market Shares of Major Suppliers

CA 15-3/27-29 Testing: Market Shares of Major Suppliers

CA 19-9 Testing: Market Shares of Major Suppliers

CEA Testing: Market Shares of Major Suppliers

PSA Testing: Market Shares of Major Suppliers

Contains 40 pages and 7 tables